Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2008-04-08
2008-04-08
Meller, Michael (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
11131538
ABSTRACT:
A nutritional supplement composition contains inhibitors of alpha-glucosidase and alpha-amylase substantially in the absence of lipase inhibitors. The composition can include touchi extract and phaseolamin as the alpha-glucosidase and alpha-amylase inhibitor, respectively. A method of limiting the absorption of carbohydrates contained in a foodstuff includes administering the nutritional supplement composition prior to consumption of the carbohydrates, and a method promoting weight loss in an individual includes administering the nutritional supplement composition to the individual over a period of days.
REFERENCES:
patent: 3934006 (1976-01-01), Frommer et al.
patent: 3950319 (1976-04-01), Schmidt et al.
patent: 4010258 (1977-03-01), Murao
patent: 5093315 (1992-03-01), Maeda et al.
patent: 5322697 (1994-06-01), Meyer
patent: 5637324 (1997-06-01), Bland
patent: 5643874 (1997-07-01), Bremer et al.
patent: 5753253 (1998-05-01), Meyer
patent: 6200958 (2001-03-01), Odaka et al.
patent: 6267988 (2001-07-01), Meyer
patent: 6299911 (2001-10-01), Kawabata et al.
patent: 6340669 (2002-01-01), Cestaro et al.
patent: 6365206 (2002-04-01), Yanai et al.
patent: 6376549 (2002-04-01), Fine et al.
patent: 6399101 (2002-06-01), Frontanes et al.
patent: 2003/0004215 (2003-01-01), Van Laere et al.
patent: 2003/0059403 (2003-03-01), Chokshi
patent: 2003/0059457 (2003-03-01), Chokshi
patent: 2003/0082168 (2003-05-01), Yegorova
patent: 2004/0018990 (2004-01-01), Rosner
patent: 1 157 696 (2001-11-01), None
patent: HEI 9-2963 (1995-06-01), None
patent: A-2000-186044 (2000-07-01), None
patent: WO 00/12080 (2000-03-01), None
patent: WO 01/17369 (2001-03-01), None
L. Quarino, J. Hess, M. Shenouda, R.R. Ristenbatt, J. Gold, R.C. Shaler, JDifferentiation of Alpha-Amylase From Various Sources: An Approach Using Selective Inhibitors, J. Forensic Sci Soc Apr.-Jun. 1993; 33(2): 87-94.
H. Fujita, T. Yamagami, K. Oshima,Fermented Soybean-Derived Water-Soluble Touchi Extract Inhibits Alpha-Glucodase and is Antiglycemic in Rats and Humans Alter Single Oral Treatment, J. Nutr Apr. 2001; 131(4): 1211-3.
H. Fujita, T. Yamagami, K. Oshima,Long-Term Ingestion of a Fermented Soybean-Derived Touchi-Extract with Alpha-Glucosidase Inhibitory Activity is Safe and Effective in Human with Borderline and Mild Type-2 Diabetes, J Nutr Aug. 2001; 131(8): 2105-8.
F. Hiroyuki, Y. Tomohide, O. Kazunori,Efficacy and Safety of Touchi Extract, An Alpha-Glucosidase Inhiboitor Derived From Fermented Soybens, in Non-Insulin-Dependent Diabetic Mellitus, J Nutr Biochem Jun. 2001; 12(6): 351-356.
H. Fujita, T. Yamagami,,Fermented Soybean-Derived Touchi-Extract with Anti-Diabetic Effect Via Alpha-Glucosidase Inhibitory Action in a Long-Term Administration Study with KKAy Mice, Life Sci Nov. 30, 2001; 70(2): 219-27.
http://www.advantagesupplements.com/advantagesupplements/bioculcarpha.html.
http://www.getbigger.com/jarrow.html.
http://www.iherbi.com/sn-1409.
http://www.iherbi.com/carb.html.
http://www.internetdietcenter.com/dynamicduo/html.
http://www.lifevigor.com/products/512101.html.
http://www.masonvitamins.com
ew%20body/carbo.htm.
http://www.pennherb.com/pennherb/info/scan54.html.
http://www.primev.com/pro701205.htm.
Touchi, http://www.nippon-sapuri.com/english/touchi.html, Nippon Supplement, Inc.
Abstract:Nutraceutical resources for diabetes prevention—an update, McCarty Mark F, NutriGuard Research, (Encinitas, Cal., USA) Medical hypotheses, (Scotland) 2005 64 (1) 151-8, ISSN 0306-9877 Journal Code: 7505668.
Abstract:Current and emerging therapies for type 2 diabetes, BioMinerva (San Diego, Cal., USA) IDrugs 7, No. 3, 249-56, 2004.
Abstract:Orlistat augments postprandial increases in glucagons-like peptide 1 in obese type 2 diabetic patients, Damci Taner; Yalin Serap; Bbalci Huriye; Osar Zeynep; Korugan Ustun; Ozyazar Mucahit; Ilkova Hasan, Istanbul University Cerrahpasa Medical School, Department of Internal Medicine, Division of Endocrinology Diabetes and Metabolism, Istanbul, Turkey: Istanbul University Cerrahpasa Medical School, Central Laboratories (Istanbul, Turkey) Journal: Diabetes care, 2004, 27 (5) 1077-1080.
Abstract:Oral antidiabetic drugs in 2003, Ducobu J, Service de Medecine Interne, C.H.U. Tivoli, La Louviere, U.L.B. Revue medicale de Bruxelles (Belgium) Sep. 2003, 24 (4) 361-8, ISSN 0035-3639 Journal Code: 8003474.
Abstract:Alpha amylase is a major allergenic component in occupational asthma patients caused by porcine pancreatic extract, Park Hae-Sim; Kim Hee-Yeon; Suh You Jin; Lee Soo-Jin; Lee Soo-Keol; Kim Sun-Sin; Nahm Dong-Ho, Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea, Journal of Asthma—official journal of the Association for the Care of Asthma (USA) Sep. 2002, 39 (6) 511-6, ISSN 0277-0903, Journal Code: 8106454.
Abstract:Inhibitors of absorption as anti-obesity drugs, Tsuji M; Saito N; Inoue S, First Department of Internal Medicine, Showa University, (Tokyo, Japan), Nippon yakurigaku zasshi, Japanese journal of pharmacology (Japan), Nov. 2001, 118 (6) 340-6,, ISSN 0015-5691, Journal Code: 0420550.
Abstract:Oral Hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers, Raptis S.A.; Dimitraiadis G.D., 2ndDepartment of Internal Medicine, Research Institute and Diabetes Center, Athens University (Athens, Greece), Experimental and clinical endocrinology & diabetes—official journal, German Society of Endocrinology and German Diabetes Association (Germany) 2001, 109 Suppl 2 265-87, ISSN 0947-7349, Journal Code: 9505926.
Abstract:Drug-induced diarrhoea, Chassany O; Michaux A; Bergmann J F, Internal Medicine Department, Lariboisiere University Hospital, Paris, France, Drug safety—an international journal of medical toxicology and drug experience (New Zealand), Jan. 2000, 22 (1) 53-72, ISSN 0114-5916, Journal Code: 9002928.
Abstract:The selective inhibition of intestinal enzymes, a new therapeutic concept, Scheen A.J.; Letiexhe M.M.; Paquot N.; Lefebvre P.J.; Prof. A.J. Scheen, Serv Diabetol, Nutr./Malad. Metabool, Department de Medicine, CHU Sart Tilman (Liege, Belgium), Medicine et hygiene (Switzerland), Aug. 25, 1999, 57/2265, 1521-1525, ISSN 0025-6749, Journal Review.
Abstract:Pharmacological treatment of obesity: Present status, Scheen A.J.; Lefebvre P.J., Prof. A.J. Scheen, Division of Diabetes, (Belgium), International Jouranl of Obesity (U.K.), 1999, 23/Suppl. 1 47-53, ISSN 0307-0565, Journal, Conference Paper.
Abstract:Intestine as a target for the pharmacological treatment of metabolic diseases, Scheen, A.J., Department de Medicine, (Belgium), Revue Medicale de Liege 1998, 53/11, 646-650, ISSN 0035-3663, Journal Article.
Abstract:Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus, Kado S.; Murakami T; Aoki A; Nagase T; Katsura Y; Noritake M.; Matsuoka T; Nagata N, (Tokyo, Japan), Diabetes Research and Clinical Practice, Jul. 1998, V41, N1 49-55, ISSN: 0168-8227, Article.
Abstract:Type 2 diabetes: new therapeutic perspectives, Bouhanick B; Berrut G; Fressinaud P; Marre M, Service de Medeicine B, Centre Hospitalier et Universitaire d'Angeres (France), Dec. 12, 1998, 27 (39), 2015-24, ISSN 0755-4982, Journal Code: 8302490.
Abstract:Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine, Scheen, A.J.; Department de Medecine, (Belgium), Nov. 1998, 53 (11) 646-50, ISSN 0370-629X, Journal Code: 0404317.
Abstract:Management of obesity in NIDDM(non-inselin-dependent diabetes mellitus), Cheah J.S., Department of Medicine, National University Hospital, (Singapore), Aug. 1998, 39 (8), 380-4, ISSN 0037-5675, Journal Code 0404516.
French Abstract:Diabete de type 2: nouveautes en therapeutique, Bouhanick B; Berrut G; Fressinaud P; Marre M, Service de Medecine B, (Angers, France), Journal: La Presse medicale: (1983), 1998, 27 (39) 2015-2023, ISSN: 0755-4982.
Abstract:Modification of Energy Density with Inhibitors of Carbohydrate and Fat, Taylor, R.H., Proc. Nutr. Soc 50, No. 2, 399-408, 1991.
Abstract:Mechanism of Action
Murray Mary A.
Roh-Schmidt Haeri
Roufs James B.
Access Business Group International LLC
Brinks Hofer Gilson & Lione
Meller Michael
LandOfFree
Nutritional supplement containing alpha-glucosidase and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nutritional supplement containing alpha-glucosidase and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutritional supplement containing alpha-glucosidase and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3940362